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Brucellosis is endemic in livestock and humans inUganda and its transmission involves amultitude of risk factors like consumption
of milk from infected cattle. To shed new light on the epidemiology of brucellosis in Uganda the present study used phenotypic and
molecular approaches to delineate the Brucella species, biovars, and genotypes shed in cattle milk. Brucella abortuswithout a biovar
designation was isolated from eleven out of 207 milk samples from cattle in Uganda.These isolates had a genomic monomorphism
at 16 variable number tandem repeat (VNTR) loci and showed in turn high levels of genetic variation when compared with other
African strains or other B. abortus biovars from other parts of the world. This study further highlights the usefulness of MLVA as
an epidemiological tool for investigation of Brucella infections.
1. Introduction
Thegenus Brucella has ten recognized species withmore than
90% DNA homology [1, 2]. These species cause brucellosis
that is of economic and public health importance in terres-
trial and aquatic animals and humans [1, 3]. Species of B.
melitensis, B. abortus, some B. suis biovars, B. canis, B. ceti,
and B. inopinata are zoonotic and in humans the infection
causes a debilitating disease with relapsing fever and flu-like
symptoms with multiple organ involvement [4–6]. In cattle
Brucella causes abortions, placentitis, orchitis, mastitis, and
prenatal death [5, 7].
Brucellosis in cattle is almost exclusively caused by B.
abortus [8], but B. melitensis and B. suis have been implicated
in some herds [9, 10] making the vaccination of cattle using
vaccines targeting only B. abortus less effective in preventing
brucellosis in cattle and transmission to humans [11, 12].
Brucella biovars and genotypes are known to be regionally
restricted in their distribution [13] but the evolution of
international travel and trade and changing ecosystems have
led to introduction of new biovars and genotypes into regions
and hosts where they were not previously found [3]. A
study done in Uganda in 1958 isolated B. abortus biovar 3
from a human patient [14] and in the neighboring Kenya
B. melitensis biovar 1 and B. abortus biovar 3 have been
isolated from cattle [9]. Phylogenetic analysis of B. melitensis
isolates in Kenya showed a high degree of homology with
isolates in Israel and the B. abortus isolates closely resembled
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that isolated in Uganda. In a related study in Egypt, B.
abortus, B. suis, and B. melitensis were isolated from cattle
and all had a high level of phylogenetic variability within
each species although the isolates used in these studies were
few [15].The above findings indicate a complex epidemiology
of brucellosis in cattle in the region and call for refined
diagnostic methods beyond phenotypic typing.
High resolution phenotypic and molecular approaches
have been developed for Brucella speciation, biotyping,
and epidemiological trace-back [16, 17]. To date, advanced
molecular technologies have not been widely used in low
income countries where brucellosis is endemic in livestock
and humans [7, 18]. Thus, information on the prevailing
Brucella species, biovars, and genotypes/strains in such areas
of endemicity may shed new light on the epidemiology of
Brucella infection and the species and biovars circulating.
Besides this generic scientific rationale for undertaking such
investigations, increased understanding of the Brucella epi-
demiology is critical for refining control of brucellosis in
resource weak countries where the same measures as in high
income countries cannot be applied.
In northern and eastern Uganda where this study was
performed, there was a considerable mixing of livestock
species during years of insurgency in the 1990s, presenting
ideal conditions for inter- and intraherd transmission of
diseases such as brucellosis. Indeed, high herd and individual
animal seroprevalences of up to 27% and 7.5%, respectively,
were recorded in a recent survey in the region [19]. This
high prevalence may pose a severe threat to public health as
previous studies around the capital of Uganda suggest milk
or milk products from cows as a major source of Brucella
infection in humans [20, 21]. The present study aimed at
isolating and molecular-typing Brucella from cattle milk in
northern and eastern Uganda for better understanding of its
epidemiology.
2. Materials and Methods
2.1. Study Design and Collection of Samples. Milk samples
were collected from 207 lactating cows in urban and peri-
urban areas of Gulu and Soroti towns of northern and
eastern Uganda from May 2011 to March 2012 for isolation
of Brucella. A total of 110 individual cow milk samples were
collected from 72 herds in Gulu and a total of 97 individual
cow milk samples were collected from 33 herds in Soroti.
These herds were part of the 166 herds whose animals had
been screened for brucellosis and were within a radius of
15 Km in both Gulu and Soroti towns, with the two towns
being 200Km apart. The cattle from which milk samples
were taken had been screened for Brucella antibodies and in
total 17 of the 207 cows were seropositive. In both towns,
the seropositive herds from which the milk samples were
taken were near each other. The numbers and selection of
households and animals included are described in detail
previously [19]. Midstreammilk samples were collected from
all quarters with 10–20mL collected from each teat into
sterile 100mL falcon tubes. The samples were transported
chilled to Makerere University College of Health Sciences
microbiology laboratory, Kampala, Uganda, kept at 4∘C, and
cultured within three days.
2.2. Sample Preparation, Brucella Culturing, and Biotyping.
The milk was centrifuged at 3000×g at 4∘C for 15 minutes
and the pellet and supernatant were plated on both Farrel
and Centro de Investigacio´n y Tecnologı´a Agroalimentaria
(CITA) selective media supplemented with calf serum [22].
Briefly, Farrel’s medium was prepared from Brucellamedium
base (Oxoid, UK), sterilized at 121∘C for 15 minutes, and
supplemented with Brucella selective supplement (Oxoid,
UK) according to the manufacturer’s instructions. The CITA
medium was prepared according to De Miguel et al. [22].
Inoculated plates were incubated at 37∘C for 8 days in a
5–10% carbon-dioxide incubator and read every 24 hours
from day three of incubation for colony growth. Resultant
colonies were subcultured and biotyped based on their
colony morphology, serum and carbon-dioxide requirement
for growth, hydrogen sulphide production, urease activity,
oxidase test, and growth in presence of dye basic fuchsin
and agglutination of anti-Brucella IgG monospecific sera
A (Animal Health and Veterinary Laboratories Agencies,
Weybridge, UK), according to theOIETerrestrialManual [8].
Representative colonies are stored at −80∘C in 20% glycerol
for long-term storage.
2.3. Genomic DNA Extraction and Real-Time PCR Detection.
The colonies that conformed to all the above phenotypic
characteristics of Brucella were subjected to genomic DNA
extraction using theNorgen bacterial genomicDNA isolation
kit (Norgen Biotek Corp., Ontario, Canada). The extracted
Brucella genomic DNAwas used to run a real-time multiplex
PCR assay with oligonucleotide primers, probes, reaction
mixture, and PCR conditions according to Probert et al.
[23]. Amplification and real-time fluorescence detectionwere
done on the Rotor-Gene 3000 real-time PCR machine (Cor-
bett Research-Corbett Life Sciences, Mort Lake Australia).
Three positive and two negative controls were included in
each run.When the cycle threshold (CT) value of the samples
was ≤40, samples were evaluated as positive. This real-time
multiplex PCR was designed to detect Brucella at both the
genus and species levels for B. abortus and B. melitensis since
it has the genus specific probe and the species specific probes
for the two Brucella species commonly infecting cattle.
2.4. Brucella Species Confirmation. Positive samples on real-
time PCR were analysed further for Brucella speciation using
the Bruce-ladder multiplex PCR assay kit (Ingenasa, Spain).
The oligonucleotide primers, reaction mixture, and PCR
conditions were performed according to the manufacture’s
conditions in conformity with Lo´pez-Gon˜i et al. [16]. How-
ever amplification was done in a MyCycler thermal cycler
(BioRad).
2.5. Characterization of Isolates by MLVA Genotyping. Geno-
typing was performed using the Multiple Locus Variable
Number Tandem Repeat Analysis (MLVA), using the 16-
primer-pair assay [17, 24–26]. The oligonucleotide primer
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Figure 1: Triplex real-time PCR amplification pattern using the
Brucella genus probe. Fluorescence ratio is plotted against the
number of PCR cycles to monitor amplification in real-time mode.
Isolates with weak Ct values (29.18 and above) had Brucella-like
phenotypic characteristics and were included in this assay.
pairs incorporated in the Brucella MLVA 16 assay target
both the conserved and highly discriminatory regions of the
Brucella genome. Each sample was run on three prescribed
MLVA panels. Panel 1 consisted of moderately polymorphic
minisatellite primer pairs targeting the highly conserved
genomic regions of different Brucella species (bruce 06, bruce
08, bruce 11, bruce 12, bruce 42, bruce 43, bruce 45, and
bruce 55). Panel 2A (bruce 18, bruce 19, and bruce 21) and
panel 2B (bruce 04, bruce 07, bruce 09, bruce 16, and bruce
30) consisted of microsatellite primer pairs targeting the
discriminatory genomic regions. The PCR amplification and
genotyping were done according to le Fle`che et al. [17] with
only a modification in the total reaction volume to 30 𝜇L.
At each run, B. suis reference strain REF. 1330 (from Bruce-
ladder kit) was included as shown in Figure 1.
2.6. Gel-Electrophoresis Analysis of Panel 1 and Panel 2 Loci
Amplification Products. Five microliters of the panel 1 and
panel 2 loci amplification products were loaded into 3% and
2% agarose gel containing ethidium bromide (0.5 𝜇g/mL),
respectively, to visualize the banding pattern in the samples
and positive controls, underUV illumination.The agarose gel
was run on 8V/cm current, and a 100 base pair and 20 base
pair ladders (BioRad) were included per run for panel 1 and
panel 2, respectively.
2.7. Sequencing the VNTR Locus Amplicons. In order to
identify repeat copy number variation among the isolates
in question the resulting PCR products were sequenced for
each VNTR locus at Macrogen, Netherlands. Sequences
were viewed using BioEDIT version 7.0.9.0. Sequencing
was performed in both directions using the M13-primers
according to Applied Biosystems (ABI). Since each of the
VNTR locus primers was tagged with M13 primer ([M13-
Forward] 5󸀠-GTAAAACGACGGCCAGT-3󸀠 and [M13-Rev]
5󸀠-GCGGATAACAATTTCACACAGG-3󸀠), this increases
each VNTR locus PCR product size by 39 base pairs.
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Figure 2: Triplex real-time PCR amplification pattern using the B.
melitensis probe. Fluorescence ratio is plotted against the number
of PCR cycles to monitor amplification in real-time mode. Only B.
melitensis (positive control) was picked by this probe.
2.8. Analysis of MLVA Sequence Data. The MLVA PCR
productswere sequenced per loci and the forward and reverse
sequences were assembled into a contig in the Bionumerics
software version 5.0 (Applied Maths, Belgium). The M13
primer tags were trimmed from the contig and the allele
designation was determined by comparing the fragment
size with the published allele numbering system (version
3.6 http://mlva.u-psud.fr Brucella support website for MLVA
typing). The number of tandem repeats per loci was queried
in the Brucella MLVA 2012 public database (http://mlva.u-
psud.fr/mlvav4/genotyping/) accessed on February 21, 2014,
for genotyping of our isolates. The closest related known
strains were determined based on the genetic distance (the
minimumnumber of changes in the number of repeats of any
locus that converts one genotype to another).
3. Results
3.1. Biotyping. Based on the biotyping (Table 1), B. abortus
biovar 1, 3, or 7 was isolated in 11 (5.3%) out of 207 milk
samples. These 11 positive samples were all from seropositive
cows (i.e., 11 of 17). The colonies being smooth eliminated B.
canis and B. ovis which have rough colonies. Production of
hydrogen sulfide eliminated B. melitensis, B. ceti, B. microti
and B. abortus biovars 5 and 6, and B. suis except B. suis
biovar 1. Ability to grow in absence of serum eliminated B.
abortus biovar 2 that generally requires serum for growth.
Brucella abortus biovar 2, B. neotomae, and B. suis biovar 1
were eliminated by their inability to grow in basic fuchsin.
Agglutination with anti-Brucella monospecific sera A elimi-
nated B. abortus biovars 4 and 9.
3.2. Molecular Characterization
3.2.1. Brucella DNA Detection by Real-Time PCR. DNA from
all the 11 isolates that was judged asB. abortus by the biotyping
was detected as Brucella DNA by the Brucella genus probe in
the triplex real-time PCR (Figure 1). However the triplex real-
time PCR was unable to detect the Brucella species involved
using its B. melitensis probe (Figure 2) and B. abortus probe
(Figure 3).
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Figure 3: Triplex real-time PCR amplification pattern using the B.
abortus probe. Fluorescence ratio is plotted against the number of
PCR cycles to monitor amplification in real-time mode. Only B.
abortus (positive control) was picked with a strong Ct value by this
probe.
3.2.2. Brucella Species Confirmation by Bruce-Ladder. DNA
from all the 11 isolates that were confirmed as belonging to the
genus Brucella in the triplex real-time PCRwas detected as B.
abortus DNA by the Bruce-ladder multiplex PCR (Figure 4).
B. abortus gives two bands of 1682 bp and 587 bp on Bruce-
ladder PCR.
3.2.3. MLVA Genotyping. The MLVA-16 assay revealed that
none of the 11 isolates did match any of the Brucella isolates
in the Brucella MLVA 2012 database but closely resembled
the former B. abortus biovar 7 strain 07-994-2411 from Kenya
(Table 2). All isolates obtained were monomorphic at all loci
as shown in Table 2 and Figure 5.We designated these isolates
as UG Ba-m because they were isolated from cattle in Uganda
and had a B. abortus profile on most biotyping assays but
resembled both B. melitensis and B. abortus at genotyping.
Both of the UG Ba-m isolates and the B. abortus strain 07-
994-2411 showed close resemblance to a human B. melitensis
biovar 1 (strain BCCN87-92) strain isolated fromUSA.When
compared on MLVA-8 panel 1 loci the genetic distance was
only zero between UG Ba-m isolates and B. abortus strain
07-994-2411 and one was between UG Ba-m isolates and B.
melitensis biovar 1 strain BCCN87-92.
4. Discussion
Here we present for the first time phenotypic and molecular
characterization of Brucella isolates from cattle milk in
Uganda. These results contribute to better understanding of
geographical transmission patterns of Brucella in cattle in
Uganda and are important if specific control measures are
to be implemented in the future. In Uganda, most of the
milk is marketed unprocessed through the informal milk
marketing linkages, thus acting as a potential source of
human brucellosis infections.
All UG Ba-m isolates were from Brucella seropositive cat-
tle conforming to the well-known fact that Brucella infected
lactating female animals shed the bacteria in their milk since
the organism relocates to the udder from the pregnant uterus
upon delivery [27]. This has public health implications in the
region since most of the milk is consumed unpasteurized.
One third of the seropositive cattle were not shedding the
Brucella in the milk suggesting that these animals either
had cleared the infection or were chronically sick, thus not
shedding the bacteria as shown in a study by Capparelli et
al. [28]. All UG Ba-m isolates being from seropositive cattle
suggest an active infection. Notably, Brucellawas not isolated
from milk from any of the seronegative cows. This suggests
that seroconversion precedes shedding of the Brucella in
milk, and thus serological tests can be sufficient in predicting
possible shedders.
The phenotypic characteristics of all UG Ba-m isolates
matched those of B. abortus biovars 1, 3 or the former
biovar 7. All isolates being B. abortus conform to the well-
known fact that B. abortus is the predominant species in
cattle [14]. Furthermore, all 11 UG Ba-m isolates having the
same phenotypic profile suggest that they belong to the same
biovar attesting to the suggestion of regional predominance of
certain Brucella biovars in Africa, for instance, predominance
of B. abortus biovar 6 in nomadic cattle in Western Sudan
[29], B. abortus biovar 3 and B. melitensis biovar 1 in cattle
in Kenya [9], and B. melitensis biovar 3 in ruminants in Egypt
[15]. However the numbers of isolates in these studies were
too few to make a solid basis for generalization.
Detection of all the 11 UG Ba-m isolates as Brucella by
the Brucella genus specific probe in the triplex real-time PCR
with strong signals confirmed them as Brucella. The inability
of the B. melitensis probe in the triplex real-time PCR to
detect the isolates as B. melitensis suggested that they are not
B. melitensis. The inability of the B. abortus species specific
probe in the triplex real-time PCR to detect the isolates as
B. abortus suggested that they are not B. abortus biovars 1, 2,
3, 4, 5, 6, and 9 but could be the former B. abortus biovar 7
since the primers used were not targeting B. abortus biovar 7
[23, 30].
All the 11 UG Ba-m isolates were confirmed as B. abortus
by the Bruce-ladder multiplex PCR. The inability of the
triplex real-time PCR to detect these isolates at its B. abortus
species specific probe contrary to the Bruce-ladder multiplex
PCR suggests that these isolates belong to the former Brucella
abortus biovar 7. This suggestion is based on the fact that
the triplex real-time PCR was not designed to detect the
former Brucella abortus biovar 7 with its B. abortus species
specific probe (detecting only B. abortus biovars 1, 2, 3,
4, 5, 6, and 9), and the Bruce-ladder multiplex PCR was
designed to detect all the B. abortus biovars including the
former B. abortus biovar 7 [16, 23, 30]. This suggests that a
diphasic PCR protocol involving the triplex real-time PCR
by Probert et al. [23] and the Bruce-ladder multiplex PCR
by Lo´pez-Gon˜i et al. [16] could be used to replace the risky
procedure of identifying the former B. abortus biovar 7 using
the conventional biotypingmethods by detecting particularly
its agglutination with monospecific anti-sera A andM and its
growth in both basic fuchsin and thionin dyes. This protocol
needs, however, to be tested on all the former B. abortus
biovar 7 isolates.
The evidence adduced using a combination of phenotypic
and molecular approaches designated all UG Ba-m isolates
as atypical B. abortus without a biovar designation. All the
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isolates were monomorphic at molecular analysis, which
could be due to the isolates being from a small geographical
region of approximately 15 Km radius per region (data not
shown here) and having been collected in a short time
frame making it possible for all the isolates to be from a
common source as animals mix in the grazing grounds. The
genetic monomorphism observed is partly congruent with
that observed in five B. melitensis biovar 1 isolates obtained
from bovine milk in central Kenya by Muendo et al. [9],
although their finding was in a different Brucella species. Our
results are further supported by findings by Garin-Bastuji
et al. [31] who found similar monomorphism in isolates in
Mongolia isolated 5 years apart in the same region. The
genetic monomorphism exhibited at the minisatellite and
microsatellite loci that are otherwise polymorphic even in
highly genetic homogenous species like Brucella suggests that
there is one or very few circulating strains of Brucella in this
region of Uganda attesting to the regional predominance of
Brucella biovars and strains.
The closest known strain for the 11 UG Ba-m isolates was
a B. abortus strain 07-994-2411 isolated from cattle in the
neighboring Kenya in 1963. This strain has no biovar desig-
nation but was formerly known as B. abortus biovar 7, before
biovar 7 was suspended from the Brucella nomenclature
(International Committee on Systematic Bacteriology, 1988).
B. abortus biovar 7 was suspended from Brucella nomencla-
ture because the reference strain (63/75) was thought to be
a mixture of B. abortus biovars 3 and 5. A recent study by
Garin-Bastuji et al. [31] proposed the reintroduction of B.
abortus biovar 7 in the approved list of bacterial names having
identified B. abortus strains from Turkey, Mongolia, and
Kenya that perfectly matched the former B. abortus biovar
7 characteristics. B. abortus biovar 7 can be differentiated
from other B. abortus biovars by its ability to agglutinate
with anti-A and anti-B monospecific sera. B. abortus biovar
7 has smooth colonies, does not require carbon dioxide for
growth, produces hydrogen sulphide, is oxidase and urease
positive, does not agglutinate with monospecific anti-sera R,
grows in the presence of dyes thionin and basic fuchsin at
a concentration of 20𝜇g/mL, and is lysed by phages Tbilisi
(Tb), Weybridge (Wb), Izatnagar 1 (LZ
1
), and R/C.
A genetic difference in the UG Ba-m isolates at 5 loci out
of 16 polymorphic loci examined compared to the known
closest related strain (07-994-2411) from Kenya in a period
of half a century could be a result of mutations and proves
the ability of MLVA to differentiate strains from different
localities, a finding congruent with that of Verger et al. [2].
The observed genetic similarity between the Kenyan strain
and the 11 UG Ba-m isolates compared to other isolates from
distant places could be due to the cross-border transmission
of Brucella in cattle that could have been facilitated by cattle
rustling across the pastoral Karamoja subregion of Uganda
and Kenya over the past years.
5. Conclusions
In conclusion, our findings suggest B. abortus without biovar
designation (atypical B. abortus) as a cause of brucellosis
in cattle in northern and eastern Uganda. The Ugandan
isolates exhibited a single MLVA-16 pattern and show in turn
high levels of genetic variation when compared with other
African strains, highlighting the usefulness of MLVA as an
epidemiological tool for investigation of Brucella infections.
Furthermore, the ability of a diphasic PCR protocol involving
the triplex real-time PCR by Probert et al. [23] and the
Bruce-ladder multiplex PCR by Lo´pez-Gon˜i et al. [16] to
detect B. abortus could be used to replace the procedure
of identifying the former B. abortus biovar 7 using the
conventional biotyping methods.
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